Matthew V Phillips - Net Worth and Insider Trading
Matthew V Phillips Net Worth
The estimated net worth of Matthew V Phillips is at least $0 dollars as of 2024-11-10. Matthew V Phillips is the Chief Commercial Officer of Avalo Therapeutics Inc and owns about 0 shares of Avalo Therapeutics Inc (AVTX) stock worth over $0. Details can be seen in Matthew V Phillips's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Matthew V Phillips has not made any transactions after 2019-06-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Matthew V Phillips
Matthew V Phillips Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Matthew V Phillips owns 1 companies in total, including Avalo Therapeutics Inc (AVTX) .
Click here to see the complete history of Matthew V Phillips’s form 4 insider trades.
Insider Ownership Summary of Matthew V Phillips
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AVTX | Avalo Therapeutics Inc | 2019-06-10 | Chief Commercial Officer |
Matthew V Phillips Latest Holdings Summary
Matthew V Phillips currently owns a total of 1 stock. Matthew V Phillips owns 0 shares of Avalo Therapeutics Inc (AVTX) as of June 10, 2019, with a value of $0.
Latest Holdings of Matthew V Phillips
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| AVTX | Avalo Therapeutics Inc | 2019-06-10 | 0 | 13.31 | 0 |
Holding Weightings of Matthew V Phillips
Matthew V Phillips Form 4 Trading Tracker
According to the SEC Form 4 filings, Matthew V Phillips has made a total of 0 transactions in Avalo Therapeutics Inc (AVTX) over the past 5 years. The most-recent trade in Avalo Therapeutics Inc is the acquisition of 0 shares on June 10, 2019, which cost Matthew V Phillips around $1,491.
Insider Trading History of Matthew V Phillips
- 1
Matthew V Phillips Trading Performance
GuruFocus tracks the stock performance after each of Matthew V Phillips's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Matthew V Phillips is 16.48%. GuruFocus also compares Matthew V Phillips's trading performance to market benchmark return within the same time period. The performance of stocks bought by Matthew V Phillips within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Matthew V Phillips's insider trading performs compared to the benchmark.
Performance of Matthew V Phillips
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 12.28 | | | | | |
| Relative Return to S&P 500(%) | 11.22 | | | | | |
Matthew V Phillips Ownership Network
Ownership Network List of Matthew V Phillips
Ownership Network Relation of Matthew V Phillips
Matthew V Phillips Owned Company Details
What does Avalo Therapeutics Inc do?
Who are the key executives at Avalo Therapeutics Inc?
Matthew V Phillips is the Chief Commercial Officer of Avalo Therapeutics Inc. Other key executives at Avalo Therapeutics Inc include director & 10 percent owner Armistice Capital Master Fund Ltd. , 10 percent owner Caissa Capital Management Ltd. , and Interim CFO Christopher Ryan Sullivan .
Avalo Therapeutics Inc (AVTX) Insider Trades Summary
Over the past 18 months, Matthew V Phillips made no insider transaction in Avalo Therapeutics Inc (AVTX). Other recent insider transactions involving Avalo Therapeutics Inc (AVTX) include a net purchase of 74,840 shares made by Caissa Capital Management Ltd. , a net sale of 3,683,542 shares made by Armistice Capital Master Fund Ltd. , and a net purchase of 4,000 shares made by Garry Arthur Neil .
In summary, during the past 3 months, insiders sold 0 shares of Avalo Therapeutics Inc (AVTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 15,348 shares of Avalo Therapeutics Inc (AVTX) were sold and 331 shares were bought by its insiders, resulting in a net sale of 15,017 shares.
Avalo Therapeutics Inc (AVTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Avalo Therapeutics Inc Insider Transactions
Matthew V Phillips Mailing Address
Above is the net worth, insider trading, and ownership report for Matthew V Phillips. You might contact Matthew V Phillips via mailing address: C/o Cerecor Inc., 400 E. Pratt Street, Suite 606, Baltimore Md 21202.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
